ClinicalTrials.Veeva

Menu

Survival and 30-days Hospital Outcome in COVID-19 Patients in Upper Egypt

A

Assiut University

Status

Completed

Conditions

Coronavirus Disease
Covid19
SARS-CoV-2

Treatments

Other: Kaplan Meier analysis

Study type

Observational

Funder types

Other

Identifiers

NCT04488588
AssiutU17

Details and patient eligibility

About

Through history, there have been plenty of pandemics however; the social response to corona virus disease (COVID-19) is unparalleled. It is assessed that almost four billion individuals are living in social segregation during this mother of all pandemics.

Initially described in China in December 2019, severe acute respiratory syndrome caused by corona virus 2 (SARS-CoV-2) has spread all over the world and by 18th July 2020- there was an emergent figure of 13,824,739 confirmed cases and 591.666 losses reported to the WHO. To date, Egypt reported slightly over 82,000 confirmed COVID-19 cases with 3858 deaths. The new pandemic is injuring not only health organizations of several countries but also the financial prudence universal.

Defining the clinical features and associated outcomes of patients diagnosed with coronavirus disease (COVID-19) is fundamental to improving our understanding and adequate management of this illness. Several articles have recently been published, describing the clinical features and outcomes of retrospective individuals with COVID-19

Enrollment

1,064 patients

Sex

All

Ages

36 to 63 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • This study included 1064 patients consecutively admitted to isolation hospitals in Upper Egypt during the period from 22 March to 23 June 2020

Exclusion criteria

  • only hospitalized confirmed cases of COVID-19 were included.

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems